(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ : 2020-08-22±³À°ÀÏÀÚ : 2020-08-22
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: ´ë±¸ È£ÅÚÀÎÅÍºÒ°í ¿¢½ºÄÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ (8/22) ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320
À̸ÞÀÏ :
office@thyroid.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í Çмú´ëȸ 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø, 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 08:30~08:45 Operative Management of Primary Papillary Thyroid Carcinoma ±è¿Ï¿í(°æºÏÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 08:45~09:00 Optimal Management for the Locally Invasive Thyroid Cancer ¾È¼øÇö(¼¿ïÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:00~09:15 Optimal Neck Dissection: How Much Surgery is Enough for the Node Positive Neck? À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:15~09:30 Intraoperative Neuromonitoring during Thyroid Surgery ±èÈÆ¿±(°í·ÁÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:45~10:05 Immune Landscape of Papillary Thyroid Cancer and Immunotherapeutic Implications ÃÖÈ«À±(¼¿ïÀÇ´ë ÇÙÀÇÇаú)
Åä·Ð 08¿ù 22ÀÏ ±×·£µåº¼·ë 10:05~10:25 Co-Expression Network Analysis with Proteogenomics Identifies Important Transcriptional Factors in Tumorigenesis and Progression of BRAFV600E Mutated Thyroid Cancer ±èÀ¯Çü(¼¿ïÀÇ´ë ³»°ú)
Åä·Ð 08¿ù 22ÀÏ ±×·£µåº¼·ë 10:25~10:45 Macrophage-Derived Endotrophin Supports Tumor Migration Potentials in Thyroid Cancer ½ÅÈ¿½Ä(¼¿ïÀÇ´ë ³»°ú)
ÈÞ½Ä 08¿ù 22ÀÏ ±×·£µåº¼·ë 10:55~11:15 Coffee Break ()
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 11:15~12:15 Current Surgical Management of Thyroid Cancer in the United States Quan-Yang Duh(University of California San Francisco)
±âŸ 08¿ù 22ÀÏ ±×·£µåº¼·ë 12:15~12:45 ÃÑȸ ()
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 12:45~13:20 Metabolic Issues to Consider When Treating Patients with Thyroid Disease ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 13:30~14:10 Metastatic Follicular Carcinoma in Pelvic Cavity Arising Struma Ovarii Á¤Á¾±æ(¿©¼öÀü³²º´¿ø ¿Ü°ú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 14:15~15:00 Development of New Technologies on the Preservation of the Parathyroid Gland and Recurrent Laryngeal Nerve during Thyroid and Parathyroid Surgery ÀÌ°´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú)
ÈÞ½Ä 08¿ù 22ÀÏ ±×·£µåº¼·ë 15:00~15:20 Coffee Break ()
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 15:20~15:40 Role of Thyroid US and CT in Active Surveillance of Low-Risk PTMC ¾ÈÇý½Å(Áß¾ÓÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 15:40~16:00 Interventional Management of Low-Risk PTMC ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 16:00~16:20 Current Stance on Active Surveillance of Low-Risk PTMC ¼Û¿µ±â(¿ï»êÀÇ´ë ³»°ú)
±âŸ 08¿ù 22ÀÏ ±×·£µåº¼·ë 16:35~17:45 Topic Highlight ()
±âŸ 08¿ù 22ÀÏ ¾ÆÀ̸®½ºÈ¦ 08:30~09:10 Free Paper 3 ()
±âŸ 08¿ù 22ÀÏ ¾ÆÀ̸®½ºÈ¦ 09:10~09:50 Free Paper 4 ()